Bill

Bill > SCR100


HI SCR100

HI SCR100
Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Long-term Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.


summary

Introduced
03/11/2022
In Committee
04/19/2022
Crossed Over
03/31/2022
Passed
Dead
05/05/2022

Introduced Session

2021 Regular Session

Bill Summary

RESOLUTION REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A THERAPEUTIC PSILOCYBIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND DEVELOP A LONGTERM STRATEGIC PLAN, should food and Drug Administration approval for medical use be obtained, TO enable the availability of therapeutic psilocybin or psilocybin-based products that are safe, accessible, and affordable for adults twenty-one years of age or older. .

Committee Categories

Budget and Finance, Business and Industry, Education, Health and Social Services

Sponsors (10)

Last Action

Report adopted; referred to the committee(s) on CPC with Representative(s) Branco voting aye with reservations; none voting no (0) and Representative(s) Hashimoto, McKelvey, Ward excused (3). (on 04/19/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...